[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Oral Rotavirus Vaccine Market Research Report Forecast 2017-2021

April 2017 | 139 pages | ID: U4A2E17E6C6EN
S&P Consulting

US$ 2,960.00 US$ 3,700.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The United States Oral Rotavirus Vaccine Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Oral Rotavirus Vaccine industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Oral Rotavirus Vaccine market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of
  • Key market segments and sub-segments
  • Evolving market trends and dynamics
  • Changing supply and demand scenarios
  • Quantifying market opportunities through market sizing and market forecasting
  • Tracking current trends/opportunities/challenges
  • Competitive insights
  • Opportunity mapping in terms of technological breakthroughs
The Major players reported in the market include:
GSK
Sanofi-Pasteur
Merck
Biological E. Limited
CSL Biotherapies
LG Life Sciences, Ltd.
Crucell
China National Biotec Group
Hualan Biological Engineering

United States Oral Rotavirus Vaccine Market: Product Segment Analysis
Type 1
Type 2
Type 3

United States Oral Rotavirus Vaccine Market: Application Segment Analysis
Application 1
Application 2
Application 3

Reasons for Buying this Report
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a six-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
CHAPTER 1 ORAL ROTAVIRUS VACCINE MARKET OVERVIEW

1.1 Product Overview and Scope of Oral Rotavirus Vaccine
1.2 Oral Rotavirus Vaccine Market Segmentation by Type
  1.2.1 United States Production Market Share of Oral Rotavirus Vaccine by Type in 2015
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Oral Rotavirus Vaccine Market Segmentation by Application
  1.3.1 Oral Rotavirus Vaccine Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Oral Rotavirus Vaccine (2011-2021)

CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON ORAL ROTAVIRUS VACCINE INDUSTRY

2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend

CHAPTER 3 UNITED STATES ORAL ROTAVIRUS VACCINE MARKET COMPETITION BY MANUFACTURERS

3.1 United States Oral Rotavirus Vaccine Production and Share by Manufacturers (2015 and 2016)
3.2 United States Oral Rotavirus Vaccine Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States Oral Rotavirus Vaccine Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Oral Rotavirus Vaccine Manufacturing Base Distribution, Production Area and Product Type
3.5 Oral Rotavirus Vaccine Market Competitive Situation and Trends
  3.5.1 Oral Rotavirus Vaccine Market Concentration Rate
  3.5.2 Oral Rotavirus Vaccine Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 UNITED STATES ORAL ROTAVIRUS VACCINE PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

4.1 United States Oral Rotavirus Vaccine Production and Market Share by Type (2012-2017)
4.2 United States Oral Rotavirus Vaccine Revenue and Market Share by Type (2012-2017)
4.3 United States Oral Rotavirus Vaccine Price by Type (2012-2017)
4.4 United States Oral Rotavirus Vaccine Production Growth by Type (2012-2017)

CHAPTER 5 UNITED STATES ORAL ROTAVIRUS VACCINE MARKET ANALYSIS BY APPLICATION

5.1 United States Oral Rotavirus Vaccine Consumption and Market Share by Application (2012-2017)
5.2 United States Oral Rotavirus Vaccine Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
  5.3.1 Potential Applications
  5.3.2 Emerging Markets/Countries

CHAPTER 6 UNITED STATES ORAL ROTAVIRUS VACCINE MANUFACTURERS ANALYSIS

6.1 GSK
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Product Type, Application and Specification
  6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Business Overview
6.2 Sanofi-Pasteur
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Product Type, Application and Specification
  6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Business Overview
6.3 Merck
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Product Type, Application and Specification
  6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Business Overview
6.4 Biological E. Limited
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Product Type, Application and Specification
  6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Business Overview
6.5 CSL Biotherapies
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Product Type, Application and Specification
  6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Business Overview
6.6 LG Life Sciences, Ltd.
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.7 Crucell
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Product Type, Application and Specification
  6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Business Overview
6.8 China National Biotec Group
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.9 Hualan Biological Engineering
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Product Type, Application and Specification
  6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Business Overview

CHAPTER 7 ORAL ROTAVIRUS VACCINE MANUFACTURING COST ANALYSIS

7.1 Oral Rotavirus Vaccine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Oral Rotavirus Vaccine

CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Oral Rotavirus Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Oral Rotavirus Vaccine Major Manufacturers in 2015
8.4 Downstream Buyers

CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

CHAPTER 11 UNITED STATES ORAL ROTAVIRUS VACCINE MARKET FORECAST (2017-2021)

11.1 United States Oral Rotavirus Vaccine Production, Revenue Forecast (2017-2021)
11.2 United States Oral Rotavirus Vaccine Production, Consumption Forecast by Regions (2017-2021)
11.3 United States Oral Rotavirus Vaccine Production Forecast by Type (2017-2021)
11.4 United States Oral Rotavirus Vaccine Consumption Forecast by Application (2017-2021)
11.5 Oral Rotavirus Vaccine Price Forecast (2017-2021)

CHAPTER 12 APPENDIX

LIST OF TABLES AND FIGURES

Figure Picture of Oral Rotavirus Vaccine
Table Classification of Oral Rotavirus Vaccine
Figure United States Sales Market Share of Oral Rotavirus Vaccine by Type in 2015
Table Application of Oral Rotavirus Vaccine
Figure United States Sales Market Share of Oral Rotavirus Vaccine by Application in 2015
Figure United States Oral Rotavirus Vaccine Sales and Growth Rate (2011-2021)
Figure United States Oral Rotavirus Vaccine Revenue and Growth Rate (2011-2021)
Table United States Oral Rotavirus Vaccine Sales of Key Manufacturers (2015 and 2016)
Table United States Oral Rotavirus Vaccine Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Oral Rotavirus Vaccine Sales Share by Manufacturers
Figure 2016 Oral Rotavirus Vaccine Sales Share by Manufacturers
Table United States Oral Rotavirus Vaccine Revenue by Manufacturers (2015 and 2016)
Table United States Oral Rotavirus Vaccine Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Oral Rotavirus Vaccine Revenue Share by Manufacturers
Table 2016 United States Oral Rotavirus Vaccine Revenue Share by Manufacturers
Table United States Market Oral Rotavirus Vaccine Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Oral Rotavirus Vaccine Average Price of Key Manufacturers in 2015
Figure Oral Rotavirus Vaccine Market Share of Top 3 Manufacturers
Figure Oral Rotavirus Vaccine Market Share of Top 5 Manufacturers
Table United States Oral Rotavirus Vaccine Sales by Type (2012-2017)
Table United States Oral Rotavirus Vaccine Sales Share by Type (2012-2017)
Figure United States Oral Rotavirus Vaccine Sales Market Share by Type in 2015
Table United States Oral Rotavirus Vaccine Revenue and Market Share by Type (2012-2017)
Table United States Oral Rotavirus Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Oral Rotavirus Vaccine by Type (2012-2017)
Table United States Oral Rotavirus Vaccine Price by Type (2012-2017)
Figure United States Oral Rotavirus Vaccine Sales Growth Rate by Type (2012-2017)
Table United States Oral Rotavirus Vaccine Sales by Application (2012-2017)
Table United States Oral Rotavirus Vaccine Sales Market Share by Application (2012-2017)
Figure United States Oral Rotavirus Vaccine Sales Market Share by Application in 2015
Table United States Oral Rotavirus Vaccine Sales Growth Rate by Application (2012-2017)
Figure United States Oral Rotavirus Vaccine Sales Growth Rate by Application (2012-2017)
Table GSK Basic Information, Manufacturing Base, Production Area and Its Competitors
Table GSK Oral Rotavirus Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
Table GSK Oral Rotavirus Vaccine Market Share (2012-2017)
Table Sanofi-Pasteur Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Sanofi-Pasteur Oral Rotavirus Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
Table Sanofi-Pasteur Oral Rotavirus Vaccine Market Share (2012-2017)
Table Merck Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Merck Oral Rotavirus Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
Table Merck Oral Rotavirus Vaccine Market Share (2012-2017)
Table Biological E. Limited Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Biological E. Limited Oral Rotavirus Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
Table Biological E. Limited Oral Rotavirus Vaccine Market Share (2012-2017)
Table CSL Biotherapies Basic Information, Manufacturing Base, Production Area and Its Competitors
Table CSL Biotherapies Oral Rotavirus Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
Table CSL Biotherapies Oral Rotavirus Vaccine Market Share (2012-2017)
Table LG Life Sciences, Ltd. Basic Information, Manufacturing Base, Production Area and Its Competitors
Table LG Life Sciences, Ltd. Oral Rotavirus Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
Table LG Life Sciences, Ltd. Oral Rotavirus Vaccine Market Share (2012-2017)
Table Crucell Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Crucell Oral Rotavirus Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
Table Crucell Oral Rotavirus Vaccine Market Share (2012-2017)
Table China National Biotec Group Basic Information, Manufacturing Base, Production Area and Its Competitors
Table China National Biotec Group Oral Rotavirus Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
Table China National Biotec Group Oral Rotavirus Vaccine Market Share (2012-2017)
Table Hualan Biological Engineering Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Hualan Biological Engineering Oral Rotavirus Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
Table Hualan Biological Engineering Oral Rotavirus Vaccine Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oral Rotavirus Vaccine
Figure Manufacturing Process Analysis of Oral Rotavirus Vaccine
Figure Oral Rotavirus Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Oral Rotavirus Vaccine Major Manufacturers in 2015
Table Major Buyers of Oral Rotavirus Vaccine
Table Distributors/Traders List
Figure United States Oral Rotavirus Vaccine Production and Growth Rate Forecast (2017-2021)
Figure United States Oral Rotavirus Vaccine Revenue and Growth Rate Forecast (2017-2021)
Table United States Oral Rotavirus Vaccine Production Forecast by Type (2017-2021)
Table United States Oral Rotavirus Vaccine Consumption Forecast by Application (2017-2021)

COMPANIES MENTIONED

GSK
Sanofi-Pasteur
Merck
Biological E. Limited
CSL Biotherapies
LG Life Sciences, Ltd.
Crucell
China National Biotec Group
Hualan Biological Engineering
Sinovac Biotech
Dalian Hissen Bio-pharm


More Publications